Clinical characteristics of ‘Flu’
description
Transcript of Clinical characteristics of ‘Flu’
![Page 1: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/1.jpg)
Hot Topic Meeting by:
Royal College of Physicians of Edinburgh & The Scottish Executive Health Department
Pandemic Flu
Planning Scotland’s Health Response
5th June 2007
Queen Mother Conference Centre
![Page 2: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/2.jpg)
Clinical characteristics of ‘Flu’
Dr Dermot H KennedyConsultant Physician in Infectious Diseases (Retd.)Glasgow
![Page 3: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/3.jpg)
“Influenza A is an unvarying disease due to a varying virus”
E. Kilbourne New York 1975
VariationComplicated:
- by pandemic virus- by co-infecting
bacteria- by risk factors
Uncomplicated:- by age- by virus type
![Page 4: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/4.jpg)
THE MENUClinical features of:• Typical influenza A
- milder complications
• Serious complications- respiratory- non respiratory
• Variation by pandemic outbreak
![Page 5: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/5.jpg)
Clinical Spectrum of Influenza A
Incidence / range of systemic features
Collated from 10 studies of 520 virologically confirmed adult cases 1937-1992 ( after Nicholson Ch. 19 in ‘Human Influenza’ )
![Page 6: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/6.jpg)
MILDER COMPLICATIONS OF INFLUENZA A
- TRACHEOBRONCHITIS- OTITIS MEDIA- SINUSITIS
- POST INFLUENZAL ASTHENIA AND DEPRESSION
![Page 7: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/7.jpg)
Who is at risk of influenza?
‘Typical’ Influenza A:
• Age <2 >65yrs• Chronic disease : respiratory, cardiac,
renal, diabetes, immunosuppression• ‘at risk’ settings• Risk factor influences presentation /
complications
Pandemic Influenza• As across• + young adults• +pregnant women
Peak mortality 1918
![Page 8: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/8.jpg)
SERIOUS COMPLICATIONS OF INFLUENZA A
RESPIRATORY:. 2y bacterial pneumonia. 1y viral pneumonitis. Mixed viral and bacterial pneumonia
. Exacerbation of COAD, asthma
NON RESPIRATORY:. CNS eg encephalopathy, myositis. CARDIAC eg decompensated CCF
![Page 9: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/9.jpg)
Complications of Influenza A Infection
2y pneumonia due to bacterial suprainfection
The problem :
![Page 10: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/10.jpg)
2y BACTERIAL PNEUMONIA
• Influenza A accounts for 5→10% of all C.A.P.
• Biphasic disease – usually• Pattern different from “CAP norm”, and between
pandemics• Pneumococcal pneumonia commonest
![Page 11: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/11.jpg)
2y bacterial pneumonia
H.influenza
pneumococcus
![Page 12: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/12.jpg)
Staphylococcal pneumonia complicating Influenza A
A sinister synergy
![Page 13: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/13.jpg)
Complications of Influenza A Virus
Iy Pneumonitis due to virus
What is role of cytokine storm?
Often fulminant and fatal Dyspnoea, wheeze, cyanosis, blood Diffuse CXR infiltrates (like ARDS) Pregnant, cardiac, young
![Page 14: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/14.jpg)
Pandemic Influenza 1918/19
• Occurred in 3 waves• Globally estimated 750m-Ib.
ill
Morbidity
• Global mortality 23-50M• UK mortality 240K• Peak mortality - young adults
Mortality
![Page 15: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/15.jpg)
Spanish ‘flu - Heliotrope cyanosis
“We have always been thankful when (facial) colour remains red …there is ample room for hope of recovery
When the colour of the patient’s face is heloitrope or mauvy-blue the prospect is grave indeed…”
1918/19
![Page 16: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/16.jpg)
H5/N1 - Z genotype traced to geese in Guangdong, China 1996
Features Avian Influenza
1997: Hong Kong - 6/18 fatal (33%)
2003/7: Asia - 175/290 fatal (60%)
Majority < 25yr old
Severe disease in: older, late presentation + pneumonia, leuko/lymphopenia (16%)
Vietnamese cases – encephalopathy + diarrhoea
Multi system involvement and Multi organ damage at Post Mortem
![Page 17: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/17.jpg)
COMPARING PANDEMICS
AGE Young Elderly Elderly
adult (young) (young)
‘notable’ S. pyogenes S. aureus S. aureus
BACTERIA + others
’18/’19 ’57/’58 ’68UK MORTALITY 240k 33k 30k E+W
![Page 18: Clinical characteristics of ‘Flu’](https://reader036.fdocuments.us/reader036/viewer/2022062408/568143eb550346895db07248/html5/thumbnails/18.jpg)
Hot Topic Meeting by:
Royal College of Physicians of Edinburgh & The Scottish Executive Health Department
Pandemic Flu
Planning Scotland’s Health Response
5th June 2007
Queen Mother Conference Centre